Assessment of Anabolic Androgenic Steroids Use Among Professional CrossFit^® Athletes: Motives, Perception, and Safety

References

• Abrahin, O., Souza, N. S. F., de Sousa, E. C., Santos, A. M., & Bahrke, M. S. (2016). Anabolic-androgenic steroid use among Brazilian women: An exploratory investigation. Journal of Substance Use, 22, 1–7. https://doi.org/10.1080/14659891.2016.1179806
   Web of Science ®Google Scholar
• Abrahin, O. S., Sousa, E. C., & Santos, A. M. (2014). Prevalence of the use of anabolic-androgenic steroids in Brazil: A systematic review. Substance Use & Misuse, 49(9), 1156–1162. https://doi.org/10.3109/10826084.2014.903750
   PubMed Web of Science ®Google Scholar
• Abrahin, O. S., Souza, N. S., Sousa, E. C., Moreira, J. K., & Nascimento, V. C. (2013). Prevalence of the use of anabolic androgenic steroids by physical education students and teachers who work in health clubs. Exercise and Sports Medicine Clinic, 19, 27–30. https://doi.org/10.1590/S1517-86922013000100005
   Google Scholar
• Albaker, W., Alkhars, A., Elamin, Y., Jatoi, N., Boumarah, D., & Al-Hariri, M. (2021). Anabolic-androgenic steroid abuse among gym users, Eastern Province, Saudi Arabia. Medicina (Kaunas, Lithuania), 57(7), 703. https://doi.org/10.3390/medicina57070703
   PubMed Web of Science ®Google Scholar
• Amaral, J. M. X., Kimergård, A., & Deluca, P. (2022). Prevalence of anabolic steroid users seeking support from physicians: A systematic review and meta-analysis. BMJ Open, 12(7), e056445. https://doi.org/10.1136/bmjopen-2021-056445
   PubMed Web of Science ®Google Scholar
• Bahrke, M. S., Yesalis, C. E., Kopstein, A. N., & Stephens, J. A. (2000). Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Medicine (Auckland, N.Z.), 29(6), 397–405. https://doi.org/10.2165/00007256-200029060-00003
   PubMed Web of Science ®Google Scholar
• Basaria, S., Wahlstrom, J. T., & Dobs, A. S. (2001). Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. The Journal of Clinical Endocrinology and Metabolism, 86(11), 5108–5117. https://doi.org/10.1210/jcem.86.11.7983
   PubMed Web of Science ®Google Scholar
• Bond, P., Smit, D. L., & de Ronde, W. (2022). Anabolic-androgenic steroids: How do they work and what are the risks? Frontiers in Endocrinology, 13, 1059473. https://doi.org/10.3389/fendo.2022.1059473
   PubMed Web of Science ®Google Scholar
• Bonnecaze, A. K., O’Connor, T., & Aloi, J. A. (2020). Characteristics and attitudes of men using anabolic androgenic steroids (AAS): A survey of 2385 men. American Journal of Men’s Health, 14(6), 1557988320966536. https://doi.org/10.1177/1557988320966536
   Web of Science ®Google Scholar
• Börjesson, A., Möller, C., Hagelin, A., Vicente, V., Rane, A., Lehtihet, M., Dahl, M. L., Gårevik, N., & Ekström, L. (2020). Male anabolic androgenic steroid users with personality disorders report more aggressive feelings, suicidal thoughts, and criminality. Medicina (Kaunas, Lithuania), 56(6), 265. https://doi.org/10.3390/medicina56060265
   PubMed Web of Science ®Google Scholar
• Brennan, B. P., Kanayama, G., & Pope, H. G.Jr (2013). Performance-enhancing drugs on the web: A growing public-health issue. The American Journal on Addictions, 22(2), 158–161. https://doi.org/10.1111/j.1521-0391.2013.00311.x
   PubMed Web of Science ®Google Scholar
• Brennan, R., Wells, J. S. G., & Van Hout, M. C. (2017). The injecting use of image and performance-enhancing drugs (IPED) in the general population: A systematic review. Health & Social Care in the Community, 25(5), 1459–1531. https://doi.org/10.1111/hsc.12326
   PubMed Web of Science ®Google Scholar
• Chang, S., Münster, A.-M. B., Gram, J., & Sidelmann, J. J. (2018). Anabolic androgenic steroid abuse: The effects on thrombosis risk, coagulation, and fibrinolysis. Seminars in Thrombosis and Hemostasis, 44(8), 734–746. https://doi.org/10.1055/s-0038-1670639
   PubMed Web of Science ®Google Scholar
• Claudino, J. G., Gabbett, T. J., Bourgeois, F., Souza, H. D S., Miranda, R. C., Mezêncio, B., Soncin, R., Cardoso Filho, C. A., Bottaro, M., Hernandez, A. J., Amadio, A. C., & Serrão, J. C. (2018). CrossFit Overview: Systematic Review and Meta-analysis. Sports Medicine - Open, 4(1), 11. https://doi.org/10.1186/s40798-018-0124-5
   PubMedGoogle Scholar
• Darke, S., Torok, M., & Duflou, J. (2014). Sudden or unnatural deaths involving anabolic-androgenic steroids. Journal of Forensic Sciences, 59(4), 1025–1028. https://doi.org/10.1111/1556-4029.12424
   PubMed Web of Science ®Google Scholar
• Dos Santos Quaresma, M. V. L., Guazzelli Marques, C., & Nakamoto, F. P. (2021). Effects of diet interventions, dietary supplements, and performance-enhancing substances on the performance of CrossFit-trained individuals: A systematic review of clinical studies. Nutrition (Burbank, Los Angeles County, CA), 82, 110994. https://doi.org/10.1016/j.nut.2020.110994
   PubMed Web of Science ®Google Scholar
• Elliot, D. L., Cheong, J., Moe, E. L., & Goldberg, L. (2007). Cross-sectional study of female students reporting anabolic steroid use. Archives of Pediatrics & Adolescent Medicine, 161(6), 572–577. https://doi.org/10.1001/archpedi.161.6.572
   PubMedGoogle Scholar
• Garcia-Arnes, J. A., & Garcia-Casares, N. (2022). Doping and sports endocrinology: Anabolic-androgenic steroids. Revista Clínica Española (Barc), 222(10), 612–620. https://doi.org/10.1016/j.rceng.2022.09.003
   PubMed Web of Science ®Google Scholar
• Harvey, O., Keen, S., Parrish, M., & van Teijlingen, E. (2019). Support for people who use anabolic androgenic steroids: A systematic scoping review into what they want and what they access. BMC Public Health, 19(1), 1024. https://doi.org/10.1186/s12889-019-7288-x
   PubMed Web of Science ®Google Scholar
• Jacob, N., Novaes, J. S., Behm, D. G., Vieira, J. G., Dias, M. R., & Vianna, J. M. (2020). Characterization of hormonal, metabolic, and inflammatory responses in crossFit(R) training: A systematic review. Frontiers in Physiology, 11, 1001. https://doi.org/10.3389/fphys.2020.01001
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Kaufman, M. J., & Pope, H. G.Jr. (2018). Public health impact of androgens. Current Opinion in Endocrinology, Diabetes, and Obesity, 25(3), 218–223. https://doi.org/10.1097/MED.0000000000000404
   PubMedGoogle Scholar
• Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502–521. https://doi.org/10.1038/bjp.2008.165
   PubMed Web of Science ®Google Scholar
• Magnolini, R., Falcato, L., Cremonesi, A., Schori, D., & Bruggmann, P. (2022). Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health, 22(1), 1371. https://doi.org/10.1186/s12889-022-13734-4
   PubMed Web of Science ®Google Scholar
• Mangine, G. T., & Seay, T. R. (2022). Quantifying CrossFit((R)): Potential solutions for monitoring multimodal workloads and identifying training targets. Frontiers in Sports and Active Living, 4, 949429. https://doi.org/10.3389/fspor.2022.949429
   PubMedGoogle Scholar
• McBride, J. A., Carson, C. C., 3rd., & Coward, R. M. (2018). The availability and acquisition of illicit anabolic androgenic steroids and testosterone preparations on the internet. American Journal of Men’s Health, 12(5), 1352–1357. https://doi.org/10.1177/1557988316648704
   PubMed Web of Science ®Google Scholar
• Meier, N., Schlie, J., & Schmidt, A. (2023). CrossFit((R)): ‘Unknowable’ or predictable?-A systematic review on predictors of CrossFit((R)) performance. Sports (Basel, Switzerland), 11(6), 112. https://doi.org/10.3390/sports11060112
   PubMedGoogle Scholar
• Neves, D., & Caldas, E. D. (2017). GC-MS quantitative analysis of black market pharmaceutical products containing anabolic androgenic steroids seized by the Brazilian Federal Police. Forensic Science International, 275, 272–281. https://doi.org/10.1016/j.forsciint.2017.03.016
   PubMed Web of Science ®Google Scholar
• Nogueira, F. R. B., A, F., Vieira, T. S., Oliveira, C. V., & Gouveia, R. L. (2014). Prevalence of the use and ergogenic resources effects by body builders in Brazilian academies: A systematic review. Gazzetta Medica Italiana Archivio per le Scienze Mediche, 173, 1–2.
   Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: A survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651. https://doi.org/10.1249/01.mss.0000210194.56834.5d
   PubMed Web of Science ®Google Scholar
• Pereira, E., Moyses, S. J., Ignácio, S. A., Mendes, D. K., Silva, D. S. D. A., Carneiro, E., Hardy, A. M. T. G., Rosa, E. A. R., Bettega, P. V. C., & Johann, A. C. B. R. (2019). Prevalence and profile of users and non-users of anabolic steroids among resistance ­training practitioners. BMC Public Health, 19(1), 1650. https://doi.org/10.1186/s12889-019-8004-6
   PubMed Web of Science ®Google Scholar
• Pope, H. G., Jr., & Katz, D. L. (1988). Affective and psychotic symptoms associated with anabolic steroid use. The American Journal of Psychiatry, 145(4), 487–490. https://doi.org/10.1176/ajp.145.4.487
   PubMed Web of Science ®Google Scholar
• Rachon, D., Pokrywka, L., & Suchecka-Rachon, K. (2006). Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed, 51(6), 392–398. https://doi.org/10.1007/s00038-006-6018-1
   PubMedGoogle Scholar
• Sagoe, D., McVeigh, J., Bjørnebekk, A., Essilfie, M.-S., Andreassen, C. S., & Pallesen, S. (2015). Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis. Substance Abuse Treatment, Prevention, and Policy, 10(1), 12. https://doi.org/10.1186/s13011-015-0006-5
   PubMed Web of Science ®Google Scholar
• Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398. https://doi.org/10.1016/j.annepidem.2014.01.009
   PubMed Web of Science ®Google Scholar
• Sagoe, D., & Pallesen, S. (2018). Androgen abuse epidemiology. Current Opinion in Endocrinology, Diabetes, and Obesity, 25(3), 185–194. https://doi.org/10.1097/MED.0000000000000403
   PubMed Web of Science ®Google Scholar
• Striegel, H., Simon, P., Frisch, S., Roecker, K., Dietz, K., Dickhuth, H. H., & Ulrich, R. (2006). Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system. Drug and Alcohol Dependence, 81(1), 11–19. https://doi.org/10.1016/j.drugalcdep.2005.05.013
   PubMed Web of Science ®Google Scholar
• Torrisi, M., Pennisi, G., Russo, I., Amico, F., Esposito, M., Liberto, A., Cocimano, G., Salerno, M., Li Rosi, G., Di Nunno, N., & Montana, A. (2020). Sudden cardiac death in anabolic-androgenic steroid users: A literature review. Medicina (Kaunas, Lithuania), 56(11), 587. https://doi.org/10.3390/medicina56110587
   PubMed Web of Science ®Google Scholar
• Trenton, A. J., & Currier, G. W. (2005). Behavioural manifestations of anabolic steroid use. CNS Drugs, 19(7), 571–595. https://doi.org/10.2165/00023210-200519070-00002
   PubMed Web of Science ®Google Scholar
• van Amsterdam, J., Opperhuizen, A., & Hartgens, F. (2010). Adverse health effects of anabolic-androgenic steroids. Regulatory Toxicology and Pharmacology, 57(1), 117–123. https://doi.org/10.1016/j.yrtph.2010.02.001
   PubMed Web of Science ®Google Scholar
• Vorona, E., & Nieschlag, E. (2018). Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding. Minerva Endocrinologica, 43(4), 476–488. https://doi.org/10.23736/S0391-1977.18.02810-9
   PubMed Web of Science ®Google Scholar
• Yu, J., Hildebrandt, T., & Lanzieri, N. (2015). Healthcare professionals’ stigmatization of men with anabolic androgenic steroid use and eating disorders. Body Image, 15, 49–53. https://doi.org/10.1016/j.bodyim.2015.06.001
   PubMed Web of Science ®Google Scholar